This episode of BioTech IQ features Kleanthis Xanthopoulos, Ph.D. He is the co-founder, chairman of the board, and CEO of Shoreline Biosciences. As part of our “What’s Ahead in Biotech: #2022” series Kleanthis talks about the power of induced pluripotent stem cells (iPSC) derived NK cells,  and macrophage immunotherapies. What is the future of immunotherapies? […]

Folate receptor alpha (FolRα) is a folate-binding protein overexpressed on ovarian and several other epithelial malignancies that can be used as a target for imaging and therapeutic strategies.[1] Higher level of FRα expression generally occurs in ovarian epithelial tumors, especially in carcinomas and ovarian serous tumors [2] According to the American Cancer Society, the incidence […]

An American company “Gaumard Scientific” designed the life-size robot “HAL S5301” with a stroke and other brain injuries in a simulation of a real patient to train medical students, and to be a substitute for actors and patients in displaying symptoms of certain conditions. It is considered the first robot in the world with a […]